Clinical Trials Browser

Phase 1/2 × Leukemia, Lymphocytic, Chronic, B-Cell × Imatinib Mesylate × Clear all

NCT00558961 2023-03-27

GL-CLB-001

Phase 1/2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell